<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>Inbox Robot: Coronary Stents News</title>
<link>http://www.inboxrobot.com/news/coronary-stents</link><description>Constantly updated news and information about a variety of topics.</description><item>
<title>CYPHER Sirolimus-eluting Coronary Stent Comparable To Bypass Surgery In Key Safety Measures In Patients With Diabetes And Multi-Vessel Disease</title>
<link>http://www.inboxrobot.com/news.php?fid=186852606</link>
<pubDate>7 Sep 2008 00:36 GMT</pubDate>
<description>
...  date indicate that the use of percutaneous coronary intervention (PCI) with the CYPHER Sirolimus-eluting Coronary Stent was comparable to bypass surgery (coronary artery bypass grafting or CABG) in key safety  ...
</description>
</item><item>
<title>Goulbourne earns NSF award to research heart stent sensors</title>
<link>http://www.inboxrobot.com/news.php?fid=186692673</link>
<pubDate>5 Sep 2008 17:29 GMT</pubDate>
<description>
...  Innovative work on a new type of heart stent sensor is earning Nakhiah Goulbourne, assistant professor  ...  of the incident can be lifesaving. A coronary stent or elastic tube implant is a permanent  ...
</description>
</item><item>
<title>Clinical Data Indicate that Percutaneous Coronary Intervention with the Cypher Sirolimus-eluting Coronary Stent Is Comparable to Bypass Surgery</title>
<link>http://www.inboxrobot.com/news.php?fid=186687077</link>
<pubDate>5 Sep 2008 17:04 GMT</pubDate>
<description>
... Clinical Data Indicate that Percutaneous Coronary Intervention with the Cypher Sirolimus-eluting Coronary Stent Is Comparable to Bypass Surgery MUNICH--(BUSINESS WIRE)--Sep 4, 2008 - Data from the largest  ...
</description>
</item><item>
<title>Invention could relieve migraine before it starts</title>
<link>http://www.inboxrobot.com/news.php?fid=186645705</link>
<pubDate>5 Sep 2008 12:51 GMT</pubDate>
<description>
...  Now, the maker of the first implantable insulin pump, the rechargeable pacemaker and various coronary stents has invented a hand-held device that targets the aura en route to stopping a  ...
</description>
</item><item>
<title>Boston Scientific reports positive data from Taxus Olympia registry</title>
<link>http://www.inboxrobot.com/news.php?fid=186605170</link>
<pubDate>5 Sep 2008 02:14 GMT</pubDate>
<description>
...  designed to analyze real-world clinical outcomes data for Boston Scientific&apos;s second-generation Taxus Liberte paclitaxel-eluting coronary stent system in the treatment of patients with coronary artery disease. The Taxus Olympia registry  ...
</description>
</item><item>
<title>Bypass Surgery Better Than Stents, Study Concludes</title>
<link>http://www.inboxrobot.com/news.php?fid=186604803</link>
<pubDate>5 Sep 2008 02:13 GMT</pubDate>
<description>
...  comparing Boston Scientific Corp.&apos;s (BSX) Taxus Express drug-coated stents with bypass surgery. The findings, revealed at  ...  funded by Boston Scientific the makers of heart stents, more than 3,000 European and U.S. patients  ...
</description>
</item><item>
<title>CYPHER SELECT Plus Sirolimus-eluting Coronary Stent Receives CE Mark Approval for Treatment of Heart Attacks</title>
<link>http://www.inboxrobot.com/news.php?fid=186562075</link>
<pubDate>4 Sep 2008 20:30 GMT</pubDate>
<description>
... CYPHER SELECT Plus Sirolimus-eluting Coronary Stent Receives CE Mark Approval for Treatment of Heart Attacks ) -- Cordis Corporation announced  ...
</description>
</item><item>
<title>Clinical Data Indicate that Percutaneous Coronary Intervention with the CYPHER(R) Sirolimus-eluting Coronary Stent Is Comparable to Bypass Surgery in Key Safety Measures in Patients with Diabetes and Multi-Vessel Disease</title>
<link>http://www.inboxrobot.com/news.php?fid=186553523</link>
<pubDate>4 Sep 2008 19:17 GMT</pubDate>
<description>
... Clinical Data Indicate that Percutaneous Coronary Intervention with the CYPHER(R) Sirolimus-eluting Coronary Stent Is Comparable to Bypass Surgery in Key Safety Measures in Patients with Diabetes and  ...
</description>
</item><item>
<title>Clinical Data Indicate that Percutaneous Coronary Intervention with the CYPHER(R) Sirolimus-eluting Coronary Stent Is Comparable to Bypass Surgery in Key Safety Measures in Patients with Diabetes and Multi-Vessel Disease Results C</title>
<link>http://www.inboxrobot.com/news.php?fid=186546858</link>
<pubDate>4 Sep 2008 18:29 GMT</pubDate>
<description>
... Clinical Data Indicate that Percutaneous Coronary Intervention with the CYPHER(R) Sirolimus-eluting Coronary Stent Is Comparable to Bypass Surgery in Key Safety Measures in Patients with Diabetes and  ...
</description>
</item><item>
<title>Study: Bypass Better Than Stents in Long Term</title>
<link>http://www.inboxrobot.com/news.php?fid=186390027</link>
<pubDate>3 Sep 2008 23:20 GMT</pubDate>
<description>
...  for by Boston Scientific, makers of the drug-coated stent used in the trial. After one year,  ...  Association. &quot;But the advantage is durability.&quot; When drug-coated stents were first introduced in 2003, they became  ...
</description>
</item><item>
<title>Invention could help some migraine sufferers</title>
<link>http://www.inboxrobot.com/news.php?fid=186352500</link>
<pubDate>3 Sep 2008 18:56 GMT</pubDate>
<description>
...  Now the maker of the first implantable insulin pump, the rechargeable pacemaker and various coronary stents has invented a hand-held device that targets the aura en route to stopping a  ...
</description>
</item><item>
<title>Hydromer, Inc. and Medinol Ltd. Enter Into a Coating Services and Supply Agreement for Stent Placeme</title>
<link>http://www.inboxrobot.com/news.php?fid=186315993</link>
<pubDate>3 Sep 2008 15:28 GMT</pubDate>
<description>
...  previously clogged arteries -- have saved millions of lives around the world. Today Medinol&apos;s coronary stents are distributed by Cordis (a Johnson &amp; Johnson company). Pebax  is a registered  ...
</description>
</item><item>
<title>--&gt; Hydromer, Inc. and Medinol Ltd. Enter Into a Coating Services and Supply Agreement for Stent Placement Catheters</title>
<link>http://www.inboxrobot.com/news.php?fid=186313617</link>
<pubDate>3 Sep 2008 15:06 GMT</pubDate>
<description>
...  previously clogged arteries -- have saved millions of lives around the world. Today Medinol&apos;s coronary stents are distributed by Cordis (a Johnson &amp; Johnson company). Pebax  is a registered  ...
</description>
</item><item>
<title>Hydromer, Inc. and Medinol Ltd. Enter Into a Coating Services and Supply Agreement for Stent Placement Catheters</title>
<link>http://www.inboxrobot.com/news.php?fid=186310606</link>
<pubDate>3 Sep 2008 14:55 GMT</pubDate>
<description>
...  previously clogged arteries -- have saved millions of lives around the world. Today Medinol&apos;s coronary stents are distributed by Cordis (a Johnson &amp; Johnson company). Pebax  is a registered  ...
</description>
</item><item>
<title>Study Shows Prasugrel Reduced Platelet Aggregation</title>
<link>http://www.inboxrobot.com/news.php?fid=186305493</link>
<pubDate>3 Sep 2008 14:27 GMT</pubDate>
<description>
...  are to undergo PCI, an artery-opening procedure that often involves the use of a coronary stent to re-open a blocked artery. 3. Bassand, JP, Hamm, C, et al. Guidelines for  ...
</description>
</item></channel>
</rss>
